These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31023256)

  • 21. Regulation and characterization of tumor-infiltrating immune cells in breast cancer.
    Dai Q; Wu W; Amei A; Yan X; Lu L; Wang Z
    Int Immunopharmacol; 2021 Jan; 90():107167. PubMed ID: 33223469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer.
    Sønderstrup IMH; Jensen MB; Ejlertsen B; Eriksen JO; Gerdes AM; Kruse TA; Larsen MJ; Thomassen M; Laenkholm AV
    Acta Oncol; 2019 Mar; 58(3):363-370. PubMed ID: 30614364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients.
    Quintayo MA; Munro AF; Thomas J; Kunkler IH; Jack W; Kerr GR; Dixon JM; Chetty U; Bartlett JM
    Breast Cancer Res Treat; 2012 Nov; 136(1):161-8. PubMed ID: 22976805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.
    Xu XL; Chen SZ; Chen W; Zheng WH; Xia XH; Yang HJ; Li B; Mao WM
    Breast Cancer Res Treat; 2013 Jun; 139(2):329-39. PubMed ID: 23670132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers.
    Green AR; Aleskandarany MA; Ali R; Hodgson EG; Atabani S; De Souza K; Rakha EA; Ellis IO; Madhusudan S
    Cancer Immunol Res; 2017 Apr; 5(4):292-299. PubMed ID: 28254786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample.
    Maia LB; Breginski FS; Cavalcanti TC; de Souza RL; Roxo VM; Ribeiro EM
    Clin Exp Med; 2016 Nov; 16(4):593-598. PubMed ID: 26409837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
    Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
    Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
    Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
    J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.
    Alvarez C; Aravena A; Tapia T; Rozenblum E; Solís L; Corvalán A; Camus M; Alvarez M; Munroe D; Maass A; Carvallo P
    BMC Cancer; 2016 Mar; 16():219. PubMed ID: 26979459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.
    Margeli M; Cirauqui B; Castella E; Tapia G; Costa C; Gimenez-Capitan A; Barnadas A; Sanchez Ronco M; Benlloch S; Taron M; Rosell R
    PLoS One; 2010 Mar; 5(3):e9499. PubMed ID: 20209131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
    Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
    J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
    Bartolucci R; Wei J; Sanchez JJ; Perez-Roca L; Chaib I; Puma F; Farabi R; Mendez P; Roila F; Okamoto T; Taron M; Rosell R
    Clin Lung Cancer; 2009 Jan; 10(1):47-52. PubMed ID: 19289372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups.
    Askeland C; Wik E; Finne K; Birkeland E; Arnes JB; Collett K; Knutsvik G; Krüger K; Davidsen B; Aas T; Eide GE; Stefansson IM; Foulkes WD; Akslen LA
    Sci Rep; 2020 Feb; 10(1):2914. PubMed ID: 32076022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
    Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
    Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.